Investing
Boston Scientific (BSX): Saving Itself Through Auctioning Off Pieces
Published:
Boston Scientific (BSX) did it shareholders a terrible disservice buy buying Guidant in a bidding war with Johnson & Johnson. It now has long-term debt of almost $8.3 billion. Troubles in its stent business have hurt earnings and the company lost money last quarter.
BSX shares which went from $13 five years ago to $44 in mid-2004, are back to $13. And, all of this is because management thought M&A would make the company bigger through cutting costs at an acquired company and relying on "synergy".
Well, it did not work, and now BSX has to auction off pieces of the company to save its skin and cover its debt service.
Boston Scientific has just sold its cardiac surgery and vascular surgery units off to Swedish company Getinge for $750 million in cash. These units went because, according to BSX, they were non-core assets.
When the going gets tough, all assets become "non-core".
Douglas A. McIntyre
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.